Anhui Huaheng Biotechnology Co. Ltd. A (688639) — Net Asset Quality Index
Anhui Huaheng Biotechnology Co. Ltd. A (688639) has a Net Asset Quality Index of 44.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥6.03 Billion minus total liabilities of CN¥3.36 Billion yields net assets of CN¥2.67 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 688639 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Anhui Huaheng Biotechnology Co. Ltd. A Net Asset Quality Index Over Time (2012–2025)
This chart shows how Anhui Huaheng Biotechnology Co. Ltd. A's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the index stands at 44.3%, representing net assets of CN¥2.67 Billion against total assets of CN¥6.03 Billion CNY. See 688639 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Anhui Huaheng Biotechnology Co. Ltd. A (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Anhui Huaheng Biotechnology Co. Ltd. A from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is Anhui Huaheng Biotechnology Co. Ltd. A worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 45.6% | CN¥2.63 Billion | CN¥5.77 Billion | CN¥3.14 Billion | ▼ -5.7 pp |
| 2024 | 51.3% | CN¥2.56 Billion | CN¥4.99 Billion | CN¥2.43 Billion | ▲ +5.3 pp |
| 2023 | 46.0% | CN¥1.83 Billion | CN¥3.97 Billion | CN¥2.14 Billion | ▼ -27.1 pp |
| 2022 | 73.1% | CN¥1.48 Billion | CN¥2.03 Billion | CN¥545.44 Million | ▼ -7.2 pp |
| 2021 | 80.3% | CN¥1.18 Billion | CN¥1.47 Billion | CN¥290.98 Million | ▲ +14.3 pp |
| 2020 | 65.9% | CN¥489.78 Million | CN¥742.89 Million | CN¥253.11 Million | ▲ +0.2 pp |
| 2019 | 65.7% | CN¥368.68 Million | CN¥561.09 Million | CN¥192.41 Million | ▲ +8.4 pp |
| 2018 | 57.3% | CN¥310.29 Million | CN¥541.13 Million | CN¥230.84 Million | ▲ +6.2 pp |
| 2017 | 51.1% | CN¥210.73 Million | CN¥412.06 Million | CN¥201.33 Million | ▲ +5.5 pp |
| 2016 | 45.7% | CN¥176.26 Million | CN¥386.04 Million | CN¥209.78 Million | ▲ +6.1 pp |
| 2015 | 39.6% | CN¥114.46 Million | CN¥289.20 Million | CN¥174.73 Million | ▲ +11.1 pp |
| 2014 | 28.5% | CN¥54.10 Million | CN¥189.91 Million | CN¥135.81 Million | ▲ +17.4 pp |
| 2013 | 11.1% | CN¥20.46 Million | CN¥184.98 Million | CN¥164.52 Million | ▲ +4.9 pp |
| 2012 | 6.2% | CN¥7.80 Million | CN¥125.90 Million | CN¥118.10 Million | — |